Keyphrases
Expectant Management
97%
Preeclampsia
85%
Confidence Interval
80%
Adjusted Odds Ratio
58%
Composite Neonatal Morbidity
48%
High Risk
40%
Between-group
40%
Maternal Morbidity
38%
Randomized Controlled Trial
38%
Headache Treatment
38%
Ovarian Cancer Survival
38%
Thrombocytosis
38%
Preeclampsia with Severe Features
35%
Retrospective Cohort Study
33%
Platelets
32%
Cesarean Delivery
32%
Cesarean Birth
31%
Venous Thromboembolism
30%
Low-risk Patients
28%
Thromboprophylaxis
26%
Neonatal Morbidity
24%
Heparin
24%
Azithromycin
23%
Medical Comorbidity
22%
Pre-delivery
22%
Ovarian Cancer Prognosis
21%
Hazard Ratio
21%
Pregnant Women
21%
Risk Stratification
21%
Adverse Perinatal Outcomes
21%
Low Risk
21%
Single Center
20%
Cesarean Section Rate
20%
Complete Mole
19%
Obstetrics
19%
Gestational Weight Gain
19%
Obesity
19%
Coexisting Fetus
19%
Gestational Diabetes Mellitus
19%
Thromboembolic Risk
19%
Dobbs
19%
Transfusion
19%
Electronic Medical Records
19%
Immediate Delivery
19%
Institutional Policy
19%
Clinical High Risk
19%
Fetus
19%
Hepatitis in Pregnancy
19%
Adverse Outcomes
19%
Anemia
19%
Medicine and Dentistry
Pre-Eclampsia
100%
Cesarean Section
71%
Odds Ratio
51%
Maternal Morbidity
43%
Randomized Controlled Trial
41%
Headache
38%
Thrombocytosis
38%
Infection
37%
Newborn Morbidity
35%
Venous Thromboembolism
34%
Platelet
34%
Gestational Age
30%
Retrospective Cohort Study
27%
Comorbidity
25%
Body Mass Index
25%
Ovarian Cancer
24%
Heparin
23%
Cancer Prognosis
21%
Azithromycin
21%
Nulliparous
21%
Wound
20%
Chorioamnionitis
19%
Anemia
19%
Adverse Outcome
19%
Thromboembolism
19%
Ovarian Cancer Survival
19%
Nerve Block
19%
Systematic Review
19%
Obstetrics
19%
Thromboprophylaxis
19%
Gestational Diabetes
19%
Hepatitis B
19%
Gestational Weight Gain
19%
Survival Analysis
19%
Paracetamol
19%
Electronic Patient Record
19%
Socioeconomic Status
19%
Proteinuria
19%
Molar Pregnancy
19%
Study Participant
19%
Hepatitis Virus
19%
Rating Scale
17%
Anticoagulation
14%
Wound Complication
14%
Bleeding
14%
Hepatitis C
14%
Nutritional Counseling
14%
Hematoma
13%
Subgroup Analysis
11%
Blood Transfusion
10%